Purple Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	19.88	21.67	18.38	28	5.85	5.2	12.18	12.13	4.2	-5.25	Upgrade
Depreciation & Amortization	0.2	0.2	0.23	0.24	0.18	0.01	0	0	0	0	Upgrade
Share-Based Compensation	1.88	2.41	2.08	2.65	1.27	0.77	2.31	0.4	0.06	0.09	Upgrade
Other Operating Activities	-41.88	-41.02	-35.95	-42.97	-12.88	-14.46	-23.12	-18.79	-7.57	0.64	Upgrade
Operating Cash Flow	-19.93	-16.74	-15.25	-12.09	-5.58	-8.48	-8.63	-6.26	-3.31	-4.53	Upgrade
Capital Expenditures	-0	-0.23	-0.12	-0.16	-0.01	-0.02	-0.01	-0.01	-0.01	0	Upgrade
Acquisitions	-3.55	0	0	0.07	0	0	-1.73	0	0	0	Upgrade
Change in Investments	16.68	19.82	10.25	-46.55	-0.59	1.97	4.41	-7.9	0	0	Upgrade
Other Investing Activities	0.76	0.32	3.27	-2.96	0.15	0.09	0.11	0.14	-	-	Upgrade
Investing Cash Flow	13.88	19.91	13.41	-49.6	-0.45	2.04	2.77	-7.77	-0.01	0	Upgrade
Share Issuance / Repurchase	6.56	1.5	1.76	74.05	6.04	8.67	3.53	12	15.13	7.2	Upgrade
Debt Issued / Paid	-0.17	-0.17	-0.15	-0.18	-0.17	0	-0.15	0	-0.29	-0.74	Upgrade
Other Financing Activities	-0.95	-0.22	-0.1	-5.38	-0.64	-0.88	-0.39	-1.71	-2.21	-0.64	Upgrade
Financing Cash Flow	5.45	1.11	1.51	68.49	5.23	7.79	3	10.29	12.63	5.82	Upgrade
Exchange Rate Effect	0	0	-0.02	0.06	0.02	0	0.05	-0.05	-0.07	-0.18	Upgrade
Net Cash Flow	-0.6	4.29	-0.33	6.8	-0.8	1.35	-2.86	-3.75	9.32	1.3	Upgrade
Free Cash Flow	-19.93	-16.96	-15.37	-12.25	-5.59	-8.5	-8.64	-6.27	-3.32	-4.53	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-849.60%	-8640.00%	-	-	-	Upgrade
Free Cash Flow Per Share	-1.00	-0.95	-8.75	-10.65	-28.87	-59.81	-9.14	-10.90	-34.46	-201.98	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).